Projects per year
Personal profile
Education
- 2017 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2003 M.D., School of Medicine, Kaohsiung Medical University
Experience
- 2022.08- Deputy Director, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
- 2022.02- Associate Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2018.05-2022.01 Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- Attending Physician, Taipei Municipal Wanfang Hospital
Research Interests
- 心臟血管生理學
- 心臟疾病
- 心臟血管藥理
- 3-D立體心臟超音波
- 心臟內科
- 心臟血行力學
- 心臟血管疾病流行病學
- 心臟血管影像
- 缺血性心臟病
- 高血壓心臟病
Fingerprint
Dive into the research topics where Cheng-Chih Chung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
以酮酸訊息傳遞、鈉氫離子交換器與第二型鈉－葡萄糖共同轉運蛋白抑制之交互作用為導向在心房病變引發心律不整之創新抗心房纖維化研究(2/3)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Ketone Signaling/Sodium Hydrogen Exchanger/ Sglt2 Inhibition as a Novel Anti-Fibrosis Target in Atrial Myopathy-Induced Arrhythmogenesis (1/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Mechanistic Insight of Pcsk9 Suppression on Atrial Fibrosis with Direct Anti-Fibrotic Activity: a Novel Therapeutic Strategy for Atrial Myopathy and Arrhythmogenesis.
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
抑制PCSK9對於改善心房纖維化之機轉以及治療心房纖維化引發心律不整治療之創新應用研究。(2/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
Mechanistic Insight of Pcsk9 Suppression on Atrial Fibrosis with Direct Anti-Fibrotic Activity: a Novel Therapeutic Strategy for Atrial Myopathy and Arrhythmogenesis.(1/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
Effect of macrophage migration inhibitory factor on pulmonary vein arrhythmogenesis through late sodium current
Chin, C. G., Chen, Y. C., Lin, Y. K., Lu, Y. Y., Cheng, W. L., Chung, C. C., Chen, S. A. & Chen, Y. J., Feb 2023, In: Europace. 25, 2, p. 698-706 9 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Empagliflozin suppressed cardiac fibrogenesis through sodium-hydrogen exchanger inhibition and modulation of the calcium homeostasis
Chung, C. C., Lin, Y. K., Chen, Y. C., Kao, Y. H., Yeh, Y. H., Trang, N. N. & Chen, Y. J., Dec 2023, In: Cardiovascular Diabetology. 22, 1, 27.Research output: Contribution to journal › Article › peer-review
Open Access -
Ceramide modulates electrophysiological characteristics and oxidative stress of pulmonary vein cardiomyocytes
Huang, S. Y., Lu, Y. Y., Lin, Y. K., Chen, Y. C., Chen, Y. A., Chung, C. C., Lin, W. S., Chen, S. A. & Chen, Y. J., Apr 2022, In: European Journal of Clinical Investigation. 52, 4, e13690.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Class I HDAC modulates angiotensin II–induced fibroblast migration and mitochondrial overactivity
Huynh, T. V., Rethi, L., Chung, C. C., Yeh, Y. H., Kao, Y. H. & Chen, Y. J., Apr 2022, In: European Journal of Clinical Investigation. 52, 4, e13712.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Disturbed Cardiac Metabolism Triggers Atrial Arrhythmogenesis in Diabetes Mellitus: Energy Substrate Alternate as a Potential Therapeutic Intervention
Lkhagva, B., Lee, T. W., Lin, Y. K., Chen, Y. C., Chung, C. C., Higa, S. & Chen, Y. J., Sept 2022, In: Cells. 11, 18, 2915.Research output: Contribution to journal › Review article › peer-review
Open Access
Datasets
-
Supplementary Material for: Novel Histone Deacetylase Inhibitor Modulates Cardiac Peroxisome Proliferator-Activated Receptors and Inflammatory Cytokines in Heart Failure
Lkhagva, B. (Creator), Lin, Y. (Creator), Kao, Y. (Creator), Chazo, T. (Creator), Chung, C. (Creator), Chen, S. (Creator) & Chen, Y. (Creator), Karger Publishers, 2015
DOI: 10.6084/m9.figshare.5128564.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Novel_Histone_Deacetylase_Inhibitor_Modulates_Cardiac_Peroxisome_Proliferator-Activated_Receptors_and_Inflammatory_Cytokines_in_Heart_Failure/5128564/1
Dataset